Mucodyne (Carbocisteine)

Carbocisteine, the active ingredient in Mucodyne, is a mucolytic presented as an oral formulation for oral use. It helps reduce the viscosity of respiratory secretions and is employed in the management of chronic bronchitis, COPD, acute productive cough and sinusitis in adult patients.

GNH USA supplies Mucodyne as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Our distribution network ensures timely delivery and reliable supply chain management across continents.

Mucodyne (carbocisteine) acts as a mucolytic to facilitate clearance of thickened airway secretions in several respiratory conditions. - Chronic bronchitis: improves sputum expectoration and reduces cough frequency. - Chronic obstructive pulmonary disease (COPD): loosens mucus, aiding breathing and lowering exacerbation risk. - Acute respiratory infections with productive cough: accelerates clearance of purulent secretions. - Sinusitis: reduces mucus viscosity in sinus passages, supporting drainage.

Carbocisteine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Nausea - Vomiting - Diarrhoea - Abdominal discomfort - Altered taste perception - Headache

Serious or Rare Side Effects: - Allergic reactions such as rash, urticaria or angioedema - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Hepatic enzyme elevation or hepatitis - Eosinophilia or neutropenia - Anaphylactic shock

When prescribing carbocisteine, clinicians should consider several safety aspects. - Renal function: assess before initiating therapy. - Hepatic impairment: use with caution and monitor liver enzymes. - Gastrointestinal upset: monitor for nausea, vomiting or diarrhoea. - Hypersensitivity: discontinue immediately if rash, angioedema or other allergic signs appear. - Pregnancy and lactation: safety not established; prescribe only if benefit outweighs potential risk. - Store at room temperature: keep in the original pack, protect from moisture.

Carbocisteine may interact with other medicines; awareness of the interaction level helps guide monitoring.

Major Interactions (Avoid): - Antitussives (e.g., codeine): may suppress cough and reduce mucociliary clearance. - Other mucolytics (e.g., N‑acetylcysteine): additive effect may increase gastrointestinal irritation.

Moderate Interactions (Monitor Closely): - Bronchodilators (e.g., salbutamol): monitor for enhanced bronchodilation. - Macrolide antibiotics (e.g., azithromycin): may increase risk of gastrointestinal upset. - Warfarin: monitor INR for potential alteration of anticoagulant effect.